- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01031147
Contrast-free Magnetic Resonance Angiography (MRA) at 3.0 T for Intracranial Aneurysm Detection
Detection of Intracranial Aneurysm With Non-enhanced, Three-dimensional Time-of-flight Magnetic Resonance Angiography(3D-TOF-MRA): a Prospective Comparison With Three-dimensional Reconstructed Digital Subtraction Angiography (3D RDSA)
Study Overview
Detailed Description
Recent years,three-dimensional time-of-flight MRA (3D-TOF-MRA) has become a useful, contrast-free method for observing intracranial vessels and is widely utilized as a screening examination for intracranial aneurysms. The studies available in Medline show mixed results.Some of these studies just included MRI/MRA in the analysis, which have a high rate of false-positives and are unreliable, and some were lack of control (ruptured aneurysm), precise numbers of false-positive results, standard images process and review, or corroborative IADSA in some patients. Furthermore, most previous studies included small sample size with aneurysm detection at 0.5-T or 1.5-T MR. Thus, these results have been inconclusive because of certain pitfalls in these studies.
Since 2007, we have conducted a clinical study to objective detection of intracranial aneurysms in our routine diagnostic work-up of intracranial aneurysms by our neuroradiologists using a standard procedure with 3D-TOF-MRA with VR at 3T. The investigators want to establish the quality data to prospectively compare 3D-TOF-MRA with VR at 3T vs 3D-RDSA in the diagnosis of intracranial aneurysms in a largest cohort of patients and test it accuracy in screening for suspected patients
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200233
- Recruiting
- The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University
-
Contact:
- Yong-Dong Li, MD, Ph.D.
- Phone Number: 0086-21-64844183
- Email: dr_liyongdong@sina.com.cn
-
Contact:
- Ming-Hua Li, MD, Ph.D.
- Phone Number: 0086-21-64844183
- Email: liminhua@online.sh.cn
-
Sub-Investigator:
- Chun Fang, MD.
-
Sub-Investigator:
- Wu Wang, MD.
-
Principal Investigator:
- Ming-Hua Li, MD, Ph.D.
-
Principal Investigator:
- Yong-Dong Li, MD, Ph.D.
-
Sub-Investigator:
- Hua-Qiao Tan, MD, Ph.D.
-
Sub-Investigator:
- Shi-Wen Chen, MD, Ph.D.
-
Sub-Investigator:
- Yuan-Chang Chen, MD.
-
Sub-Investigator:
- Jia-Ying Zhang, MD.
-
Sub-Investigator:
- Ding-Jun Hu, MD.
-
Sub-Investigator:
- Qing Wu, MD.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Suspected or known intracranial aneurysms
Exclusion Criteria:
- Patient's inability to cooperate
- Chronic renal failure patients
- Any patients with a contraindication to MRA examination, such as pacemaker, orbital metallic foreign body, coronary stent, etc.
- Any patients with a contraindication to DSA examination, such as allergic to contrast medium, etc.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Magnetic resonance angiography
Three-dimensional time-of-flight magnetic resonance angiography(3D-TOF-MRA) was used to detect the intracranial aneurysms in this study
|
3D-TOF-MRA was performed for suspected patients to detect intracranial aneurysm, and subsequently underwent digital subtraction angiography
Other Names:
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASC3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.